Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers
S Shanehsazzadeh, MA Oghabian… - Nuclear medicine …, 2013 - journals.lww.com
Methods Ultrasmall superparamagnetic iron oxide (USPIO) was successively labeled with
67 Ga-chloride after chelation with freshly prepared cyclic DTPA-dianhydride. The labeling …
67 Ga-chloride after chelation with freshly prepared cyclic DTPA-dianhydride. The labeling …
[引用][C] Image-based dosimetry for the optimization of liver radioembolization with 90Y microspheres
Δ Πλαχούρης - 2022
Planning dosimetry for 90Y radioembolization with glass microspheres: Evaluating the fidelity of 99mTc‐MAA and partition model predictions
MA Thomas, A Mahvash, M Abdelsalam… - Medical …, 2020 - Wiley Online Library
Purpose 99mTc‐MAA‐SPECT/CT may be used in 90Y‐glass microsphere
radioembolization treatment planning to assess perfused liver volumes and absorbed dose …
radioembolization treatment planning to assess perfused liver volumes and absorbed dose …
A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin …
YH Kao - Journal of Nuclear Medicine, 2013 - Soc Nuclear Med
TO THE EDITOR: At first glance, the results of a recent study by Wondergem et al.(1) may
appear discouraging for the evolving science of personalized predictive dosimetry for 90Y …
appear discouraging for the evolving science of personalized predictive dosimetry for 90Y …
MIRDy90: A Software Tool for 90Y Microsphere Treatment-Planning Calculations
P1163 Introduction: Surrogate 99m Tc-MAA planar or SPECT imaging is used to calculate
several image-based parameters as part of the treatment-planning protocol for 90 Y …
several image-based parameters as part of the treatment-planning protocol for 90 Y …
[HTML][HTML] Evaluation of the Efficacy and Safety of the ITM 68Ge/68Ga Generator After its Recommended Shelf-life
T Sriprapa, T Doungta, N Sakulsamart… - Siriraj Medical …, 2023 - he02.tci-thaijo.org
Objective: 68 Ga can be routinely produced by a 68 Ge/68 Ga generator without the need for
a cyclotron. It is recommended to replace the 68 Ge/68 Ga generator after 250 elutions or 12 …
a cyclotron. It is recommended to replace the 68 Ge/68 Ga generator after 250 elutions or 12 …
Microspheres for liver radiomicrospheres therapy and planning
A Amor-Coarasa - 2013 - digitalcommons.fiu.edu
Liver cancer accounts for nearly 10% of all cancers in the US. Intrahepatic Arterial
Radiomicrosphere Therapy (RMT), also known as Selective Internal Radiation Treatment …
Radiomicrosphere Therapy (RMT), also known as Selective Internal Radiation Treatment …
PET and MR imaging with 64Cu/68Ga-labeled AGuIX ultra-small nanoparticles in tumor-bearing mice
1181 Objectives To determine tumor targeting by MRI and PET imaging with ultra-small
gadolinium-based nanoparticles, AGuIX, AGuIX-68 Ga and AGuIX-NODA-64 Cu, in a 4T1 …
gadolinium-based nanoparticles, AGuIX, AGuIX-68 Ga and AGuIX-NODA-64 Cu, in a 4T1 …
Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing 99mTc-MAA and 90Y-microspheres radioembolization
N Noipinit, C Sukprakun, P Siricharoen… - Annals of Nuclear …, 2024 - Springer
Purpose This study aimed to determine the absorbed doses in the tumoral-liver and non-
tumoral liver of hepatocellular carcinoma (HCC) patients undergoing radioembolization with …
tumoral liver of hepatocellular carcinoma (HCC) patients undergoing radioembolization with …
Radionuclide therapies in molecular imaging and precision medicine
AT Kendi, VM Moncayo, JA Nye, JR Galt, R Halkar… - PET clinics, 2017 - pet.theclinics.com
With recent advances in molecular imaging and cancer therapy, a rapid growth in
radionuclide therapy as part of precision medicine is expected. Dual-purpose therapeutic …
radionuclide therapy as part of precision medicine is expected. Dual-purpose therapeutic …